Concord Biotech Ltd
NSE:CONCORDBIO
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
PlayAGS Inc
NYSE:AGS
|
Hotels, Restaurants & Leisure
|
| US |
|
BlackRock Inc
NYSE:BLK
|
Financial Services
|
| US |
|
MGM Resorts International
NYSE:MGM
|
Hotels, Restaurants & Leisure
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Citigroup Inc
NYSE:C
|
Banking
|
| US |
|
Penn National Gaming Inc
NASDAQ:PENN
|
Hotels, Restaurants & Leisure
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Coinbase Global Inc
NASDAQ:COIN
|
Financial Services
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
| US |
|
Microsoft Corp
NASDAQ:MSFT
|
Technology
|
| US |
|
Amazon.com Inc
NASDAQ:AMZN
|
Retail
|
| US |
|
First Solar Inc
NASDAQ:FSLR
|
Semiconductors
|
| US |
|
Tesla Inc
NASDAQ:TSLA
|
Automobiles
|
| UK |
|
Cadence Minerals PLC
LSE:KDNC
|
Metals & Mining
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 253.1
2 601.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
PlayAGS Inc
NYSE:AGS
|
US |
|
|
BlackRock Inc
NYSE:BLK
|
US |
|
|
MGM Resorts International
NYSE:MGM
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Citigroup Inc
NYSE:C
|
US |
|
|
Penn National Gaming Inc
NASDAQ:PENN
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Coinbase Global Inc
NASDAQ:COIN
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
|
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
|
Amazon.com Inc
NASDAQ:AMZN
|
US |
|
|
First Solar Inc
NASDAQ:FSLR
|
US |
|
|
Tesla Inc
NASDAQ:TSLA
|
US |
|
|
Cadence Minerals PLC
LSE:KDNC
|
UK |
This alert will be permanently deleted.
Concord Biotech Ltd
Total Assets
Concord Biotech Ltd
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Concord Biotech Ltd
NSE:CONCORDBIO
|
Total Assets
₹17B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Total Assets
₹388.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Total Assets
₹346.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Total Assets
₹881.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Total Assets
₹150.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Total Assets
₹119.6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Concord Biotech Ltd
Glance View
Concord Biotech Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2023-08-18. Concord Biotech Limited is an India-based research and development driven biopharma company. The firm is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The firm manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic processes and finished formulations. The company manufactures fermentation and semi-synthetic based products in the therapeutic segments, such as immunosuppressants, anti-bacterial, oncology, anti-fungal and others. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Vancomycin Hydrochloride, Micafungin Sodium, Mupirocin, Romidepsin, Dactinomycin, and Pravastatin Sodium, among others. The company also has a pipeline of API products under development. Its API products under development include Polymyxin B, Fidaxomicin, Doxorubicin, and others. The firm provides products in the critical care, immunology, nephrology, and transplant medicine segments.
See Also
What is Concord Biotech Ltd's Total Assets?
Total Assets
17B
INR
Based on the financial report for Mar 31, 2024, Concord Biotech Ltd's Total Assets amounts to 17B INR.
What is Concord Biotech Ltd's Total Assets growth rate?
Total Assets CAGR 3Y
13%
Over the last year, the Total Assets growth was 12%. The average annual Total Assets growth rates for Concord Biotech Ltd have been 13% over the past three years .
You don't have any saved screeners yet
